Director, CVM Biomarkers & Translational Science

C028 (FCRS = CH028) Novartis Pharma AG; Basel; Hybrid; CHF 142.000 - 264.000; Vollzeit

Benefits dieser Stelle

Hybrid working

Parental leave

Insurance plans

Retirement plans

Zusammenfassung

Novartis Pharma AG in Basel, Switzerland seeks a Director-level Cardiovascular and Metabolism Therapeutic Area Biomarker Lead to develop and implement fit-for-purpose biomarker strategies. You will guide projects from early to late-stage development and interface with Translational Data Science teams.

The role requires MD/PhD or PhD, 5+ years leading multidisciplinary teams, and expertise in omics, imaging, statistics, and data science.

Qualifikationen

• MD/PhD or PhD required.
• Experience in cardiovascular/metabolic disease biomarker development is highly preferred.
• Strong leadership in multidisciplinary matrix teams including pharma/biotech.

Aufgaben

• Deliver biomarker strategies across early to late phase.
• Lead matrixed SME and program stakeholders.
• Represent biomarker development on disease boards and drive novel endpoints.

Kenntnisse

Biomarker strategy

Leadership

Genomics

Biostatistics

Clinical trials

Ausbildung

MD/PhD or PhD degree

Jobbeschreibung

Novartis Pharma AG in Basel, Switzerland seeks a Director-level Cardiovascular and Metabolism Therapeutic Area Biomarker Lead to develop and implement fit-for-purpose biomarker strategies. You will guide projects from early to late-stage development and interface with Translational Data Science teams.

The role requires MD/PhD or PhD, 5+ years leading multidisciplinary teams, and expertise in omics, imaging, statistics, and data science.